Departments of Laboratory Medicine and Neurosurgery, Sakra World Hospital, Bangalore, India.
Int J Surg Pathol. 2024 May;32(3):511-514. doi: 10.1177/10668969231188897. Epub 2023 Jul 24.
Concurrent occurrence of schwannoma and meningiomas are rare, and are found especially in association with neurofibromatosis type 2 (NF2). Occurrence of mixed tumor without the aforementioned conditions is extremely rare. We present three cases of mixed tumor in different locations, including two with NF2 and one without NF2. We analyse the relationship of mixed tumor with NF2 and its clinical implications. Presence of mixed schwannoma-meningioma should prompt screening for NF2. Thus aids in early diagnosis of unsuspected NF2 cases. We observed that irrespective of different locations, cases with NF2 showed frequent recurrence of schwannoma as compared to case who did not fit in the existing clinical criteria for NF2. Collision tumor and thereby NF2 mutations indicates the prognosis and recurrence of the tumor, thereby guides in deciding the management.
神经鞘瘤和脑膜瘤同时发生的情况很少见,尤其与神经纤维瘤病 2 型(NF2)有关。在没有上述情况的情况下,发生混合瘤的情况极为罕见。我们报告了三例不同部位的混合瘤,其中两例伴有 NF2,一例不伴有 NF2。我们分析了混合瘤与 NF2 的关系及其临床意义。存在混合性神经鞘瘤-脑膜瘤应提示筛查 NF2。因此有助于早期诊断未被怀疑的 NF2 病例。我们观察到,无论位置如何,伴有 NF2 的病例与不符合现有 NF2 临床标准的病例相比,神经鞘瘤的复发更为频繁。碰撞瘤和 NF2 突变提示肿瘤的预后和复发,从而指导治疗决策。